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ABSTRACT
Introduction: Several studies have reported
approaches used in improving the delivery of
prevention of mother-to-child transmission (PMTCT)
of HIV services through the involvement of male
partners, but evidence from a systematic review is
limited. We aim at determining the impact of male
partner involvement on PMTCT in sub-Saharan
Africa.
Methods and analysis: This will be a systematic
review of published literature. Interventional and
observational studies on male involvement in PMTCT
carried out in sub-Saharan Africa will be included
irrespective of the year and language of publication.
OVID Medline, Embase, PschINFO, and Cochrane
database of controlled trials will be searched. After
manual searching of articles, authors shall be
contacted for further information. 2 authors (NFT
and CJ) will independently screen potential articles
for eligibility using defined inclusion and exclusion
criteria. Critical Appraisal Skills Programme (CASP)
tools, Jadad scale and the STROBE checklist will be
used for critical appraisal, and the 2 authors will
independently assess the quality of articles. Authors
will independently extract data from studies using a
pre-established data collection form, and any
discrepancies will be sorted by a third author (TRK).
Outcomes will be analysed using STATA V.12.0. The
random effect model will be used to produce forest
plots. The heterogeneity χ2 statistics and I2 will be
used to assess for heterogeneity. Publication bias will
be assessed using funnel plots. This protocol is
reported according to the Preferred Reporting Items
for Systematic Reviews and Meta-Analysis Protocols
(PRISMA-P) 2015 guidelines.
Ethics and dissemination: No ethical approval
since included studies will be published studies that
had already obtained ethical approvals. The findings
will guide HIV programmes on the best approaches
towards involving male partners in PMTCT with a
view to improving PMTCT services in sub-Saharan
Africa.
PROSPERO registration number: 42016032673.
INTRODUCTION
Rationale
Globally, there are 35 million people living
with HIV, with the majority (71%) located in
sub-Saharan Africa (SSA).1 2 Of the 3.2 million
children living with HIV globally, 91% live in
SSA and in 2013, 240 000 new HIV infections
occurred in children which is equivalent to 1
child being infected every 2 min.1 The risk of
mother-to-child transmission is between 25%
and 35% in developing countries, and evi-
dence suggests that with prevention interven-
tions, such as antiretrovirals, the risk can be
reduced to <10%.3 Interventions directed
towards the improvement of prevention of
mother-to-child transmission (PMTCT) of HIV
services, such as antenatal testing for pregnant
women, safe delivery practices, safe infant
breastfeeding practices, maternal antiretroviral
therapy (ART), and infant antiretroviral
prophylaxis have resulted in the prevention of
HIV in some 670 000 children in SSA between
2009 and 2012.1 4 However, the lack of involve-
ment of male partners in such PMTCT ser-
vices has been found to discourage pregnant
women from taking part in the services, and
hence may result in even more new paediat-
ric infections.5 6 Consequently, there has
been increasing need to develop approaches
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that can get male partners involved in PMTCT services
since their involvement will be crucial in achieving a sus-
tained reduction of mother-to-child transmission of HIV,
which is an important step towards the attainment of the
elimination of HIV transmission from mother-to-child by
2030.7
Several approaches that have been used to improve on
the male involvement in PMTCT services involve rando-
mised controlled trials (RCTs) and cohort study designs,
but evidence from a systematic review is limited. Sherr
and Croome8 attempted a review that was aimed at
exploring these approaches, but the findings from this
review were limited to communication between couples
and community involvement approaches. Limitations of
this review include: database search limited to Medline,
PsycINFO and Cochrane database; article selection by a
single author and no flow chart showing how articles
were screened; no assessment of the quality of articles to
be included; no conference abstract used; no experts
consulted; and articles limited to English language. All
these caveats strongly suggest the review was not suffi-
ciently systematic, and the high risk of selection bias sug-
gests that not all the studies at the time were included.
In addition, the more recent approaches that were
attempted and were not included in their review com-
prise community-based interventions;9 home visits;10 self-
testing;11 use of peer-based and structural strategies;12
communication among spouses;13 HIV status disclos-
ure;14 and co-enrolment of partners.15
The evidence on the impact of male partner involve-
ment approaches on PMTCT services has been contrast-
ing. A systematic review by Brusamento et al16 explored
the impact on some services which included: HIV coun-
selling and testing; antiretroviral prophylaxis in women
and infants; and enrolment into care. This systematic
review was rigorous in methodology as it explored
several databases and thoroughly assessed the quality of
studies. However, the investigators limited the search to
articles published after the year 2000 despite evidence
that mother-to-child transmission of HIV prevention
strategies were reported as early as 1985 by the Centres
for Disease Control and Prevention (CDC).17
Furthermore, only one study at the time of completion
of the literature search met the inclusion criteria, and
hence only information from that single study was used
in providing evidence on the impact of male participa-
tion on PMTCT services. The evidence from this single
included study suggested that male partner involvement
has a negative impact on the delivery of PMTCT services.
This finding is not consistent with many currently pub-
lished studies that have reported a positive impact of
male partner involvement on some primary PMTCT ser-
vices. For example, Weiss et al18 has reported an increase
in infant prophylaxis, Myer et al15 reported an increase
in ART initiation rates,19 Kalembo et al20 reported
impact on the proportion of hospital deliveries, Osoti
et al11 reported the impact on HIV status disclosure and
Orne-Gliemann et al21 have reported the impact on
antenatal HIV testing in pregnant women. Other recent
studies have reported the impact on secondary PMTCT
services such as condom use among partners,20 uptake
of identification of serodiscordant couples,11reduction
of intimate partner violence,22 enrolment and retention
in care.9 Therefore, a systematic review to address this
contrasting evidence is needed.
The gaps presented in the studies above prompted the
need to conduct an up-to-date systematic review on the
approaches that have been used in improving on male
partner involvement, and the impact these have had on
PMTCT services such as counselling and testing by
couples, hospital deliveries, HIV disclosure and anti-
retroviral initiation.
General objective
The overall aim of the study will be to determine the
approaches used to improve male participation in
PMTCT of HIV, and the impact that these approaches
have on the PMTCT of HIV services in SSA.
Research questions
What approaches have been used to improve on male
involvement in PMTCT in SSA?
What impacts does male involvement have on the
uptake of PMTCT services such as couple testing and
counselling, and couple and infant initiation on ART in
SSA?
Specific research objectives
1. To develop a literature search strategy for the
approaches used in improving male partner partici-
pation in PMTCT of HIV and assess the impact these
approaches have on the uptake of PMTCT of HIV ser-
vices in SSA.
2. To screen all the identified studies in (1) for rele-
vance to the research questions.
3. To critically appraise the literature obtained from
objective (2).
4. To extract relevant data from studies in (3) on
approaches used in improving male partner partici-
pation in PMTCT services in SSA.
5. To extract relevant data from studies in (3) on the
impact of the approaches in (4) on PMTCT of HIV
services in SSA.
6. To draw conclusions on the impacts of approaches
used in improving male partner involvement on the
delivery of PMTCT services such as couples counsel-
ling and testing, hospital deliveries, HIV disclosure,
and antiretroviral initiation by couples.
METHODS
Eligibility criteria
Study designs
The review will include RCTs, cluster randomised trials,
non-randomised controlled studies, cohort studies (both
prospective and retrospective), and repeated cross-
2 Takah NF, et al. BMJ Open 2016;6:e012224. doi:10.1136/bmjopen-2016-012224
Open Access
group.bmj.com on July 12, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
sectional studies. One time cross-sectional studies and
case-control studies will be excluded because these will
not present any evidence of the impact of male partner
involvement. The studies that will be included to answer
the research question should investigate an approach or
approaches used in improving male partner involvement
in PMTCT, and provide data on the impact of the
approach(es) on the delivery of PMTCT services at any
level.
Participants
Studies that explore the approaches towards involving
male partners irrespective of age who have pregnant
partners irrespective of marital status, living in the same
house or not, will be included. No distinction will be
made with respect to maternal age or number of preg-
nancies. Interventions directed to all males and/or preg-
nant partners and infants will be included.
Study setting
Since our review is focused on the SSA region, only
studies carried out in this setting will be included.
Community-based studies, clinic-based or home-based
studies will all be included. Studies carried out in urban
and rural settings will be included. Studies will be
included irrespective of language, year of publication
and duration of follow-up.
Source of information
The methods of this systematic review will be reported in
accordance with the Preferred Reporting Items for
Systematic Reviews and Meta-Analysis Protocols
(PRISMA-P) 2015.23 The items of these checklists as ful-
filled by this protocol are shown in online supplemen-
tary table S1.
Search strategy and study identification
Main database search
Using medical subject headings (MeSH) and text key
words, literature will be searched relating to male
partner participation and PMTCT in SSA. The databases
to be searched include OVID Medline, OVID Embase,
PubMed, PsycINFO, Cochrane library, Cochrane data-
base of controlled trials, and ClinicalTrials.gov, WHO
database of controlled trials.
A detailed planned search strategy for MEDLINE and
EMBASE is shown in box 1.
Reference list
The reference list of relevant articles will be searched to
identify any relevant studies.
After identifying the main relevant studies, the journal
in which these were published will be handsearched for
any unidentified studies. These journals will be listed in
the final review.
For studies that will be selected for critical appraisal,
the authors will be contacted by email for the existence
of any unpublished literature or research in progress or
unpublished data.
Grey literature
Other general and less precise search engines such as
Google and Google scholar will be searched using key
words like ‘male partner’ and ‘HIV’, ‘male partner’ and
‘PMTCT’, and ‘male’. This search will help obtain grey
literature that will be screened by the two reviewers.
Study records
Data management
All identified studies shall be uploaded into the
Mendeley software V.1.15.3 for de-duplication of records.
The full texts and abstracts will be uploaded into the
Rayyan software to facilitate internet-based collaboration
between investigators during the selection of articles. A
standard pretested questionnaire containing inclusion
and exclusion criteria will be drafted to guide the
screening of titles and abstracts.
Screening
Various folders will be created in the Mendeley refer-
ence management software, and duplicate results will be
removed using the reference management system. Two
independent reviewers (the principal investigator and
the study supervisor) will screen titles of search results
and abstracts. Reviewers will settle any disagreements
using the inclusion criteria and outcomes of interest,
and a third reviewer will be sought in case of any diffi-
culty to arrive at an agreement by the other two
reviewers. Excluded studies will be filed in different
folders with the reasons for exclusion clearly stated. A
PRISMA flow diagram will reflect this process.
Data extraction
A standardised data extraction sheet will be produced in
Excel V.2013, and data from the different studies will be
extracted by two independent reviewers. These sheet will
be pretested and amended by two investigators (NFT
and CJ) before data collection begins. Should any dis-
agreement between reviewers arise, it will be settled by
discussion with a third reviewer (ITRK).
Data items
The data extracted will include the following items:
▸ Authorship, year of study, and journal
▸ Country where study was conducted
▸ Objectives
▸ Study design
▸ Inclusion and exclusion criteria
▸ Study duration
▸ Sample size
▸ Characteristics of participants
▸ Services targeted by approaches
▸ Study setting (clinic based, community based or
home based)
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Box 1 Detailed planned search strategy
SEARCH STRATEGY FOR MEDLINE, EMBASE AND HPSI
Database: Ovid MEDLINE(R) <1946 to February Week 2 2016>, Embase <1996 to 2016 Week 08>, Health and Psychosocial Instruments
<1985 to January 2016>
Search Strategy:
1. *HIV/
2. *HIV infection/
3. human immunodeficiency virus.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb,
yr, ar, bs, bt, cf, dp, ja, pa, so]
4. human immuno-deficiency virus.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb,
yr, ar, bs, bt, cf, dp, ja, pa, so]
5. human immune-deficiency virus.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb,
yr, ar, bs, bt, cf, dp, ja, pa, so]
6. human immunedeficiency virus.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb,
yr, ar, bs, bt, cf, dp, ja, pa, so]
7. (human immun* and deficiency virus).mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd,
jn, pb, yr, ar, bs, bt, cf, dp, ja, pa, so]
8. *AIDS/pc
9. acquired immune-deficiency syndrome.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd,
jn, pb, yr, ar, bs, bt, cf, dp, ja, pa, so]
10. acquired immunedeficiency syndrome.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn,
pb, yr, ar, bs, bt, cf, dp, ja, pa, so]
11. acquired immunodeficiency syndrome.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd,
jn, pb, yr, ar, bs, bt, cf, dp, ja, pa, so]
12. (acquired immune* and deficiency syndrome).mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo,
pg, sd, jn, pb, yr, ar, bs, bt, cf, dp, ja, pa, so]
13. Infectious disease transmission.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb,
yr, ar, bs, bt, cf, dp, ja, pa, so]
14. vertical transmission.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs,
bt, cf, dp, ja, pa, so]
15. vertical infectious disease transmission.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd,
jn, pb, yr, ar, bs, bt, cf, dp, ja, pa, so]
16. *Sexually Transmitted Diseases/pc
17. *Sexually Transmitted Diseases, viral/
18. mother-to-child transmission.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr,
ar, bs, bt, cf, dp, ja, pa, so]
19. Parent-to-child transmission.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr,
ar, bs, bt, cf, dp, ja, pa, so]
20. Maternal-to-child transmission.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr,
ar, bs, bt, cf, dp, ja, pa, so]
21. maternal-fetal infection transmission.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn,
pb, yr, ar, bs, bt, cf, dp, ja, pa, so]
22. MTCT.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf, dp, ja, pa,
so]
23. PMTCT.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf, dp, ja,
pa, so]
24. pPTCT.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf, dp, ja,
pa, so]
25. male partner*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf,
dp, ja, pa, so]
26. spouse*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf, dp, ja,
pa, so]
27. husband*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf, dp, ja,
pa, so]
28. couple*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf, dp, ja,
pa, so]
29. fathers*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf, dp, ja,
pa, so]
30. men*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf, dp, ja, pa,
so]
4 Takah NF, et al. BMJ Open 2016;6:e012224. doi:10.1136/bmjopen-2016-012224
Open Access
group.bmj.com on July 12, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
▸ Type of approaches used (such as psychosocial,
medical, community and peer group)
▸ Expected outcomes
▸ Results of actual outcomes measured, that is the
effect sizes: mean differences, differences in propor-
tions, relative risks (RRs), ORs, p values.
Outcomes of interest
The primary outcomes will include:
▸ Proportion of pregnant women attending antenatal
clinics
▸ Proportion of couples counselled and tested for HIV
▸ Proportion of women testing for HIV
▸ Proportion of male partners testing for HIV
▸ Proportion of pregnant women and infants who are
receiving antiretrovirals (ARVs)
The secondary outcomes will include:
▸ Proportion of couples who use condoms
▸ Proportion of mothers who engage in safe infant
breastfeeding practices
▸ Proportion of mothers who come for hospital
deliveries
▸ Proportion of women who use/intend to use family
planning.
Assessment of methodological quality and risk of bias
Critical appraisal
Critical appraisal will be done to assess for bias and con-
founding. Using the Critical Appraisal Skills Programme
(CASP) tool for observational and experimental studies,
a template for results of critical appraisal will be develo-
ped to capture the following aspects:
▸ Aims of the study and if these were stated clearly
▸ Whether the right study design was used
▸ Method of recruitment of participants
▸ Exclusion criteria
▸ Response and follow-up rate
▸ Extent to which the sample is representative
▸ Presentation of results
▸ Consistency with other studies.
The critical appraisal will be carried out independ-
ently by two investigators (NFT and CJ). Strengths and
weaknesses of the methodology of each study will be
considered individually in order to arrive at a decision.
Assessment of risk of bias
This assessment will be carried out independently by the
two reviewers (NFT and CJ). Further assessment of risk
of bias and quality of the studies will be done using the
Jadad scale24 for randomised trials, and the STROBE
checklist25 for observational studies. Box 2 shows the
items in the Jadad scale.
Box 1 Continued
31. sexual partner*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf,
dp, ja, pa, so]
32. prevention*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf, dp,
ja, pa, so] (924849)
33. reduc*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf, dp, ja,
pa, so]
34. educat*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf, dp, ja,
pa, so]
35. (awareness or health promotion or safe sex or condom* or efficacy or efficiency or behav* or test* or notif* or contact tracing* or
prophylaxis*).mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, tn, dm, mf, dv, kw, ac, sh, de, md, ip, vo, pg, sd, jn, pb, yr, ar, bs, bt, cf,
dp, ja, pa, so]
36. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12
37. 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24
38. 25 or 26 or 27 or 28 or 29 or 30 or 31
39. 32 or 33 or 34 or 35
40. 36 and 37 and 38 and 39.
Box 2 The Jadad scale for assessment of quality of
randomised trials
Quality assessment using the Jadad scale for randomised
controlled trials
A commonly used three-item, five-point quality scale was used to
rate the quality of the trials (Jadad et al24). The minimum score
possible for inclusion of a study in the review was 2 (1 point
each for randomisation and double-blinding). The maximum
score possible was 5 (2 points for descriptions of randomisation,
2 points for descriptions of double blinding, and 1 point for
descriptions of withdrawals).
How points are awarded:
1. Is the study randomised? If yes, +1 point.
2. Is the randomisation procedure appropriate and reported in
the study?
3. If yes, +1 point. If no, delete all points awarded for
randomisation.
4. Is the study double-blinded? If yes, +1 point.
5. Is the double-blinding method appropriate and reported in the
study?
6. If yes, +1 point. If no, delete all points awarded for
double-blinding.
7. Are the reasons for patient withdrawals and dropouts
described for each treatment group?
8. If yes, +1 point.
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Data synthesis, analysis and assessment for heterogeneity
The information on the data extraction sheet will be
exported to STATA V.12. Heterogeneity will be tested in
STATAV.12 using the Q statistic and I2, with level of stat-
istical significance set at 0.05. If the I2=25–49% we will
consider a ‘low’ heterogeneity, I2=50–74% will be consid-
ered as ‘moderate’ heterogeneity and I2≥75% will be
considered as ‘high’ heterogeneity. If data are inappro-
priate for quantitative synthesis, we will proceed with
qualitative synthesis only. With low heterogeneity, we will
proceed with meta-analysis with pooled effect sizes pre-
sented as forest plots. The random effect model will be
used to produce forest plots. The effect sizes could be
mean differences, differences in proportions, ORs, RRs,
and p values. Publication bias will be assessed using
funnel plots and the Egger’s test.
Sensitivity analysis
If substantial heterogeneity is detected, subgroup analysis
will be performed to identify possible sources of hetero-
geneity with the following grouping variables: age group,
study setting, study quality, study design, method of ran-
domisation. Subgroup differences will be described and
interpreted accordingly.
Confidence in cumulative evidence
The strength of evidence provided by the studies
included in this review was obtained by using the
Grading of Recommendations Assessment Development
and Evaluation (GRADE) approach. This approach will
assess the risk of bias, consistency and publication bias.
Studies will be described as ‘high’, ‘moderate’, ‘low’ and
‘very low’ quality if further research is unlikely to change
the estimates, likely to have considerable impact on
effect estimates, capable of changing effect sizes,
respectively.
Reporting of this review
This review will be published according to PRISMA
guidelines and the PRISMA checklist will be published
with the completed report.23
Potential amendments
No further protocol amendment is envisaged in order
to avoid any possibility of reporting bias. However, any
amendment in the final report will be explained clearly.
Ethical consideration and dissemination of findings
This study will require no ethical approval since no inter-
vention will be carried out on a human subject, and the
studies that will be selected for the review had already
obtained ethical approval before they were conducted.
The studies will be published studies, conference
abstracts, and grey literature that are ‘freely’ available
and accessible.
It is expected that this study will provide evidence on the
impact of approaches that have been used so far in improv-
ing the involvement of male partners in PMTCT. We
expect to present approaches that have improved the pro-
portion of couples testing for HIV, improved the rate of
HIV status disclosure among couples, and improved the
proportion of couples and infants on ART in SSA. This evi-
dence is currently needed by Ministries of Health, HIV
funding agencies, and HIV implementation partners to
guide the efforts towards effectively involving male partners
in PMTCT to ensure the elimination of mother-to-child
transmission of HIV in sub-Saharan Africa.16
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